<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>GuosenHealthcare | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-23T11:22:13+08:00</updated>
  <subtitle>国信医药最新研究成果、行业深度资讯展示与交流平台，引领健康投资、健康生活新风尚！</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>【国信医药】眼科产业链：服务为首，器械唯新，药物为基（医疗大数据系列报告三）</title>
    <updated>2020-11-23T09:25:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/8-B_jzakDwUrxK9guPCcSg</id>
    <link href="https://mp.weixin.qq.com/s/8-B_jzakDwUrxK9guPCcSg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国信证券年度策略会医药组专场|邀请函</title>
    <updated>2020-11-23T09:25:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/vOpn_ir_MudsENkT7JUZ5g</id>
    <link href="https://mp.weixin.qq.com/s/vOpn_ir_MudsENkT7JUZ5g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】板块延续回调趋势，静待医保谈判落地（周观点）</title>
    <updated>2020-11-22T22:08:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/PNZYmeuzShZ0L95e9jSF1Q</id>
    <link href="https://mp.weixin.qq.com/s/PNZYmeuzShZ0L95e9jSF1Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国信证券年度策略会医药组专场|邀请函</title>
    <updated>2020-11-22T22:08:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/Vln_z9TEIN4InvtOIA9jHw</id>
    <link href="https://mp.weixin.qq.com/s/Vln_z9TEIN4InvtOIA9jHw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】新冠疫苗有效性数据优秀，调整中关注龙头投资机会（周观点）</title>
    <updated>2020-11-15T22:14:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/GZhArODaGcwo7vAyrYGzWw</id>
    <link href="https://mp.weixin.qq.com/s/GZhArODaGcwo7vAyrYGzWw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】全球首个新冠疫苗中期分析显示保护力超90%（行业重大事件快评）</title>
    <updated>2020-11-10T17:57:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/NZpXOTshXtMDVrxfBeizsw</id>
    <link href="https://mp.weixin.qq.com/s/NZpXOTshXtMDVrxfBeizsw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】冠脉支架集采大幅降价，医药板块弱势调整（周观点）</title>
    <updated>2020-11-08T22:02:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-08:/s/IcoUtyVme2J8zsHZ8qi0QQ</id>
    <link href="https://mp.weixin.qq.com/s/IcoUtyVme2J8zsHZ8qi0QQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】以岭药业：疗效至上，临床循证是王道（三季报点评）</title>
    <updated>2020-11-07T17:30:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-07:/s/phX9_ZtSHoif3QbqRSI0nQ</id>
    <link href="https://mp.weixin.qq.com/s/phX9_ZtSHoif3QbqRSI0nQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】冠脉支架集采结果公布，中标价大幅下降 （行业重大事件快评）</title>
    <updated>2020-11-06T09:55:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/k63cOBPQyMaVlFJ2awQMWA</id>
    <link href="https://mp.weixin.qq.com/s/k63cOBPQyMaVlFJ2awQMWA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】华润三九：销售费率下降，Q3利润翻番（三季报点评）</title>
    <updated>2020-11-05T09:56:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/b_a1PsBcmlOalj0a0RNWmA</id>
    <link href="https://mp.weixin.qq.com/s/b_a1PsBcmlOalj0a0RNWmA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】政策迭出、靴子落地，布局龙头“黄金坑”（2020年11月投资策略）</title>
    <updated>2020-11-04T16:07:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/tnD8qmyAXqYOLn738_xiDQ</id>
    <link href="https://mp.weixin.qq.com/s/tnD8qmyAXqYOLn738_xiDQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】欧洲疫情二次爆发，关注三季报业绩边际变化（周观点）</title>
    <updated>2020-11-02T10:53:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/kqTqM1vzy6r4UhXOiILmkg</id>
    <link href="https://mp.weixin.qq.com/s/kqTqM1vzy6r4UhXOiILmkg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】华兰生物：疫苗高速增长，血制品表现平淡（三季报点评）</title>
    <updated>2020-11-02T10:53:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/rrKj1GmvTtrpcE5t9pn3oA</id>
    <link href="https://mp.weixin.qq.com/s/rrKj1GmvTtrpcE5t9pn3oA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】贝瑞基因：肿瘤早筛优质赛道，数据持续优化（三季报点评）</title>
    <updated>2020-11-02T10:53:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/XzdluBIxLual2oAeNFBtIg</id>
    <link href="https://mp.weixin.qq.com/s/XzdluBIxLual2oAeNFBtIg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】上海医药：研发加码持续，创新开花可期（三季报点评）</title>
    <updated>2020-11-02T10:53:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/P_UgFFfOHe9dTL9NMc8Sww</id>
    <link href="https://mp.weixin.qq.com/s/P_UgFFfOHe9dTL9NMc8Sww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>